SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-22-200492
Filing Date
2022-07-25
Accepted
2022-07-25 08:40:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d346919dsc14d9.htm SC 14D9 471555
2 EX-99.(A)(1)(G) d346919dex99a1g.htm EX-99.(A)(1)(G) 5912
3 EX-99.(A)(5)(B) d346919dex99a5b.htm EX-99.(A)(5)(B) 119851
4 GRAPHIC g346919g01a01.jpg GRAPHIC 52332
5 GRAPHIC g346919g01a02.jpg GRAPHIC 47865
  Complete submission text file 0001193125-22-200492.txt   733061
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-44849 | Film No.: 221101303
SIC: 2836 Biological Products, (No Diagnostic Substances)